ADGM Stock Analysis: Buy, Sell, or Hold?
ADGM - Adagio Medical Holdings, Inc Common Stock
$0.50
-0.03 (-5.66%)
βΌ
5d:
-12.43%
30d:
-28.57%
90d:
-67.74%
WAIT
LOW Confidence
Analysis Updated: Jul 20, 2026 12:00 AM ET
Earnings: Aug 12, 2026
22d
Get Alerted When ADGM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: ADGM is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: ADGM is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADGM is currently trading at $0.50, which is considered oversold relative to its 30-day fair value range of $0.56 to $0.70.
Technical Outlook: Technically, ADGM is in a strong downtrend. The price is currently testing key support at $0.51. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: ADGM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.33 (+528.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADGM is in a strong downtrend. The price is currently testing key support at $0.51. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: ADGM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.33 (+528.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.56 -
$0.70
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.7%)
- BULLISH: Trading 528.9% below Wall St target ($3.33)
- WARNING: Recommendation downgraded due to -12.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.56 -
$0.70
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.51
Resistance Level
$0.68
Current Trend
Strong Downtrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.39
Wall Street Target
$3.33
(+528.9%)
Revenue Growth (YoY)
75.6%
Share & Embed Analysis
Last updated: July 20, 2026 1:50 PM ET
Data refreshes hourly during market hours. Next update: 2:50 PM
Data refreshes hourly during market hours. Next update: 2:50 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADGM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$72 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$99 | 55 HOLD |
|
GEHC
GE HealthCare Technologi⦠|
STRONG BUY
21 analysts |
$79 | 62 BUY |